ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,333Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 153

$604K Total Retail Price of All Prescriptions

Rank: 7 out of 153

521 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wyoming
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 521 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 521 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 9,125 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wyoming
LEVOTHYROXINE SODIUM 459 423 1 1
OMEPRAZOLE 363 358 2 4
HYDROCODONE-ACETAMINOPHEN 296 245 S3 3 5
FUROSEMIDE 267 257 4 6
LISINOPRIL 267 259 4 3
SIMVASTATIN 255 232 6 2
AMLODIPINE BESYLATE 213 204 7 7
HYDROCHLOROTHIAZIDE 198 195 8 9
METOPROLOL TARTRATE 180 159 9 11
CITALOPRAM HBR 173 166 10 14
MELOXICAM 167 130 11 27
WARFARIN SODIUM 164 150 12 10
TRAZODONE HCL 155 137 13 32
ATENOLOL 151 129 14 18
METFORMIN HCL 142 118 15 8
POTASSIUM CHLORIDE 139 129 16 12
GABAPENTIN 137 116 17 15
ATORVASTATIN CALCIUM 128 114 18 19
ALENDRONATE SODIUM 115 112 19 22
TAMSULOSIN HCL 105 100 20 24
ALLOPURINOL 100 100 21 25
NAMENDA 99 99 22 28
ESCITALOPRAM OXALATE 97 91 23 55
ADVAIR DISKUS 87 83 24 31
FLUOXETINE HCL 86 63 25 51
SUCRALFATE 83 83 26 90
PREDNISONE 82 79 27 29
CLONIDINE HCL 81 69 28 105
METOPROLOL SUCCINATE 80 71 29 13
LOSARTAN POTASSIUM 77 76 30 17
PROAIR HFA 75 56 31 58
GLYBURIDE 74 67 R 32 84
CYMBALTA 71 52 33 39
CELEBREX 69 68 34 67
PRAVASTATIN SODIUM 68 61 35 20
BYSTOLIC 67 58 36 64
DIGOXIN 66 64 37 40
NAPROXEN 63 59 38 82
DONEPEZIL HCL 62 62 39 26
RANITIDINE HCL 62 53 39 53
SPIRIVA 61 58 41 35
LYRICA 60 28 42 87
TRAMADOL HCL 60 53 42 23
TRIAMTERENE-HCTZ 60 60 42 49
AZITHROMYCIN 59 52 45 43
JANUVIA 58 58 46 63
FENTANYL 55 52 S2 47 56
NEXIUM 53 48 48 37
ENALAPRIL MALEATE 52 48 49 42
SERTRALINE HCL 51 38 50 16
GEMFIBROZIL 51 38 50 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.